Aleks
@aradovicm
Followers
416
Following
2K
Statuses
369
Passionate about speeding innovation to patients. #SarcomaAwareness🎗 Scientist, entrepreneur, Latino-Slavic-American 🇨🇱 🇷🇸 🇺🇸
Joined April 2013
Awesome to have Melissa @NextechInvest aboard for this critical part of the journey
We are excited to announce the closing of our $92M series C financing! This milestone will enhance our efforts in advancing BE-101 for Hemophilia B through clinical proof of concept and progress BE-102 for Hypophosphatasia to the clinic.
0
0
1
RT @bebiopharma: We are excited to announce the closing of our $92M series C financing! This milestone will enhance our efforts in advancin…
0
1
0
RT @LongwoodLeaders: Thank you @docrodwong @RtwLp @Mpmcapital @engineventures @Jeito_life @aradovicm @LongwoodFund for sharing your insig…
0
2
0
Wow a positive (?) note from @adamfeuerstein ! My life has peaked? 😆
@avidresearch $VOR is really interesting.
0
0
3
@jrkelly Safe & effective delivery systems for nucleic acids and proteins that reach any/all tissues/cells of interest. Or clever workarounds. Solve delivery and R&D success will be transformed 🙌
0
0
0
RT @LongwoodLeaders: A fantastic end to the day hearing investor perspectives on the environment. Thank you @citi @MPMCapital @JPMorganAM @…
0
2
0
Discussing investor perspectives in election season this coming Tuesday w/ tremendous panelists: Ansbert Gadicke (MPM), Claudine Prowse (JPM), Dean Dimizas (Cambridge Assoc), and Yigal Nochomovitz (Citi) 😊
0
1
3
RT @VorBio: We are excited to share new VBP101 clinical data that validates our approach of using shielded transplants to deliver targeted…
0
3
0
RT @jgooten: How can AI change biological research? In a new perspective, we (+@omarabudayyeh ) cover the potential for revolutions, rangi…
0
22
0
Cool work @seattlechildren et al - using plasma cells (PC) that secrete bispecific antibodies to treat cancer. Because the PCs home to bone marrow, the local effects are pronounced. PCs can engraft in marrow without toxic conditioning & can be redosed, offering many advantages
We’re excited to announce that we’ve been published in the journal Molecular Therapy. The article written in collaboration with our founders at SCRI, covers an oncology application. Read it here: #BeBio #Oncology
0
0
6
Nice pun
Companies are engineering B cells to produce gene-encoded medicines, but clinical proof of concept is needed to convince the doubters that this platform can deliver
0
1
2
RT @bebiopharma: Thrilled to announce the clearance of our IND from the FDA for BE-101 for the potential treatment of hemophilia B. We expe…
0
4
0
RT @LongwoodFund: Congratulations to @LongwoodFund portfolio company @bebiopharma on the IND clearance from @US_FDA! Onwards to help patien…
0
2
0
RT @LongwoodFund: We're thrilled to announce the latest Longwood portfolio company, Progentos Therapeutics. Congratulations on the Series A…
0
2
0
RT @bebiopharma: Be Bio will present new preclinical data highlighting our novel approach using engineered B-cell Medicines (BCMs) as a pot…
0
2
0
RT @LongwoodFund: We're thrilled to share the news on our latest investment, Engrail Therapeutics Read the releas…
0
1
0
RT @LongwoodFund: A thoughtful write-up from the @BostonGlobe on the uniting power of #science, profiling repeat Longwood scientists and en…
0
5
0
RT @VorBio: Congratulations to our scientific founder, @DrSidMukherjee, on being elected to the @theNAMedicine and honored for his contribu…
0
1
0
RT @LongwoodLeaders: Up Now: @genentech CEO Alexander Hardy and @JMaraganore on the importance and impact of #340b Drug Pricing & Reforms @…
0
3
0